Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease
Status:
COMPLETED
Trial end date:
2025-09-09
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo parallel-controlled Phase II clinical trial to evaluate the efficacy and safety of TJ0113 capsule in patients with early-stage Parkinson's disease
Phase:
PHASE2
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators:
Hangzhou PhecdaMed Co., Ltd. Huzhou Central Hospital Sir Run Run Shaw Hospital Taizhou Hospital Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University The Second Affiliated Hospital of Jiaxing University Wenzhou Central Hospital